CHEK2 and breast cancer: In line with previous research [15,16,54,55,56,57] and unlike BRCA1 and PALB2-associated BCs that commonly present triple-negative subtype [58,59], ATM and CHEK2-related BC in our population mostly resulted in luminal-like subtypes.